What's New?
Keep up to date with the latest cutting-edge science.
23rd January 2025
OpenAI and Retro Biosciences: Redefining Longevity with GPT-4b Micro
In a groundbreaking leap toward advancing longevity science, OpenAI, in partnership with Retro Biosciences, has introduced GPT-4b Micro—an AI model designed to revolutionize the quest for extending human life. Unlike conventional anti-aging approaches, GPT-4b Micro harnesses the transformative potential of artificial intelligence to unlock new possibilities in regenerative medicine.
At its core, GPT-4b Micro is tailored for biological research, with a primary focus on optimizing Yamanaka factors—proteins capable of reprogramming adult cells into versatile stem cells. This advanced AI model dramatically accelerates the process of stem cell production, achieving efficiency levels over 50 times greater than natural proteins. Such breakthroughs are set to redefine the landscape of regenerative medicine.
Trained on a vast dataset of protein sequences, GPT-4b Micro excels at proposing bold, innovative modifications to proteins—suggestions that would be difficult, if not impossible, to explore using traditional laboratory techniques. The potential applications of this technology are immense, offering hope for treating age-related diseases, repairing or replacing damaged organs, and potentially increasing the average human lifespan by up to a decade.
With GPT-4b Micro, OpenAI and Retro Biosciences are not just pushing the boundaries of science—they're reshaping the future of human health and longevity.